Regional Analysis
North America is expected to be the largest market for transcranial magnetic stimulators during the forecast period, accounting for over 41.5% of the market share in 2023. The growth of the market in North America is attributed to the rising prevalence of neurological diseases, favorable reimbursement policies, and the presence of leading TMS manufacturers in the region.
Europe is expected to be the second-largest market for transcranial magnetic stimulators, accounting for over 29.6% of the market share in 2023. The growth of the market is attributed to the increasing adoption of TMS therapy and technological advancements in TMS devices in the region.
Asia Pacific is expected to be the fastest-growing market for transcranial magnetic stimulators, growing at a CAGR of over 22.9% during the forecast period. The growth of the market in Asia Pacific is attributed to the expanding patient pool, improving healthcare infrastructure, and growing awareness about TMS therapy in the region.